01/27/2026
Gluten labeling is under closer FDA review.
The FDA has announced new steps to improve gluten ingredient disclosure on food labels, including a formal Request for Information (RFI). The agency is seeking data on the presence of gluten from grains like barley, rye, and oats, as well as information on cross-contact during manufacturing.
This is an early signal that gluten disclosure expectations may expand beyond current allergen requirements and is an opportunity to review ingredient sourcing, supplier documentation, and gluten testing strategies.
👉 Manufacturers and industry professionals can review and submit comments through the FDA’s RFI here: https://www.fda.gov/news-events/press-announcements/fda-takes-steps-improve-gluten-ingredient-disclosure-foods
Today, the U.S. Food and Drug Administration issued a Request for Information (RFI) regarding labeling and preventing cross-contact of gluten in packaged food.